THE DEAL, AT A GLANCE
From the announcementImmuneel
01What it doesImmuneel is a Bengaluru-based Digital Health company focused on scale CAR-T therapies.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by a mix of new, </strong>, Singularity AMC, including founder Kiran Mazumdar-ShawFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedImmuneel raised Series B, announced 2026-06-08From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersImmuneel’s $0M Series B places a Bengaluru CAR-T scaling company inside a heavily active Healthcare & Life Sciences funding tape, where the primary signal is sector…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Immuneel · Financing Record
Explore source-linked visual explanations for Immuneel. Unsupported claims are withheld while source review continues.
Record 5703 · Recorded date: 2026-06-08
Explore company records →